Robert Hugh Jones - and Velindre Cancer Centre, Cardiff University

基本信息

浏览量：53

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 19 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Efficacy and Safety of Dendrimer-Enhanced (DEP) Cabazitaxel (DEP CTX) in Patients with Advanced Solid Cancers in a Phase 1/2 Trial (P1/2)

James F. Spicer,David James Pinato,Martin Forster,Anthony M. Joshua,James Korolewicz, Karam Aboud,Cienne Morton, Jia Jenny Liu,Rasha Cosman, Nicola Jane Main, Julia Le Meur, Jeremy Paull, Stephanie Ruth Edmondson,Robert Hugh Jones

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Efficacy and Safety of Dendrimer-Enhanced (DEP) Cabazitaxel (CTX-SPL9111) in Advanced Esophagogastric Cancers in a Phase 1/2 Trial

David James Pinato,Robert Hugh Jones,Martin D. Forster,Anthony M. Joshua,James Korolewicz,Sarah Benafif, Karam Aboud, Jia Jenny Liu,Rasha Cosman, Jeremy Paull,Jacinth Fairley, Stephanie Ruth Edmondson,James F. Spicer

JOURNAL OF CLINICAL ONCOLOGYno. 3_SUPPL (2024): 374-374

引用0浏览0引用

Figure S4 from Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor–positive Breast Cancer

Robert B. Jones,Jonathan Farhi,Miranda Adams,Kiran K. Parwani,Garrett W. Cooper,Milica Zecevic,Richard S. Lee,Andrew L. Hong,Jennifer M. Spangle

crossref（2023）

引用0浏览0引用

Fulvestrant Plus Vandetanib Versus Placebo for the Treatment of Patients with Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy (FURVA): a Multicentre, Phase 2, Randomised Controlled Trial

Mark Beresford,Angela Casbard, Zoe Hudson,Margherita Carucci,Kate Ingarfield,Julia Gee,Joanna Smith,Terri Kitson,Fouad Alchami,Tracie-Ann Madden, Larrie Hayward, David Hwang,Saiqa Spensley,Simon Waters,Duncan Wheatley,Robert H. Jones

BJC reportsno. 1 (2023)

引用0浏览0WOSNATURE引用

Supplementary Table ST1 from Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor–positive Breast Cancer

Robert B. Jones,Jonathan Farhi,Miranda Adams,Kiran K. Parwani,Garrett W. Cooper,Milica Zecevic,Richard S. Lee,Andrew L. Hong,Jennifer M. Spangle

crossref（2023）

引用0浏览0引用

Fulvestrant Plus Capivasertib Versus Placebo after Relapse or Progression on an Aromatase Inhibitor in Metastatic, Oestrogen Receptor-Positive, HER2-negative Breast Cancer (FAKTION): Overall Survival, Updated Progression-Free Survival, and Expanded Biomarker Analysis from a Randomised, Phase 2 Trial

Sacha J. Howell,Angela Casbard,Margherita Carucci,Kate Ingarfield,Rachel Butler,Sian Morgan,Magdalena Meissner,Catherine Bale,Pavel Bezecny,Sarah Moon,Chris Twelves,Ramachandran Venkitaraman,Simon Waters,Elza C. de Bruin,Gaia Schiavon,Andrew Foxley,Robert H. Jones

Lancet oncology/Lancet Oncologyno. 7 (2022): 851-864

引用29浏览0WOS引用

Abstract P1-04-10: Breast cancer survivors exhibit an accumulation of CD4+ central memory T cells, a fall in CD8+ naïve T cells and higher activation of CD4+/CD8+ memory T cells in blood, which is positively correlated with age and fat mass index

Ainhoa Arana Echarri,Lauren Struszczak,Mark Beresford,John P Campbell,Robert H Jones,Rachel Butler,Dylan Thompson,James E Turner

Cancer Research（2022）

引用0浏览0引用

A Phenomic Perspective on Factors Influencing Breast Cancer Treatment: Integrating Aging and Lifestyle in Blood and Tissue Biomarker Profiling

Ainhoa Arana Echarri,Mark Beresford,John P. Campbell,Robert H. Jones,Rachel Butler,Kenneth J. Gollob,Patricia C. Brum,Dylan Thompson,James E. Turner

Frontiers in immunology (2021): 616188-616188

引用3浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn